GT Biopharma Inc. (GTBP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GT Biopharma Inc.

    NASDAQ: GTBP · Real-Time Price · USD
    0.80
    -0.06 (-7.15%)
    At close: Sep 09, 2025, 11:45 AM

    GT Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -14.36M -13.58M -21.26M -57.52M
    Interest Income
    		 402K 780K 292K 38K
    Pretax Income
    		 -13.16M -7.6M -20.88M -58.01M
    Net Income
    		 -13.16M -7.6M -20.88M -58.01M
    Selling & General & Admin
    		 8.57M 7.11M 12.45M 47.92M
    Research & Development
    		 5.8M 6.47M 8.81M 9.59M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 14.36M 13.58M 21.26M 57.52M
    Interest Expense
    		 n/a 213K 8K 718K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.36M 13.58M 21.26M 57.52M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 1.9M 1.35M 31.87M 28.16M
    Shares Outstanding (Diluted)
    		 1.9M 1.35M 31.87M 28.16M
    EPS (Basic)
    		 -6.94 -5.64 -0.66 -2.06
    EPS (Diluted)
    		 -6.94 -5.64 -0.66 -2.06
    EBITDA
    		 -13.16M 5.98M -20.96M -57.48M
    EBIT
    		 -13.16M -7.6M -20.88M -57.54M
    Depreciation & Amortization
    		 n/a 13.58M n/a n/a

    Add to Watchlist